Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer

Despite the treatment of lung adenocarcinoma (LUAD) having partially improved in recent years, LUAD patients still have poor prognosis rates. Therefore, it is especially important to explore effective biomarkers and exploit novel therapeutic developments. High-throughput technologies are widely used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chin-Chou, Shen, Wan-Jou, Anuraga, Gangga, Khoa Ta, Hoang Dang, Xuan, Do Thi Minh, Chen, Sih-Tong, Shen, Chiu-Fan, Jiang, Jia-Zhen, Sun, Zhengda, Wang, Chih-Yang, Wang, Wei-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784538/
https://www.ncbi.nlm.nih.gov/pubmed/36556168
http://dx.doi.org/10.3390/jpm12121947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784538/
https://www.ncbi.nlm.nih.gov/pubmed/36556168
http://dx.doi.org/10.3390/jpm12121947

Ejemplares similares